1. Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk
- Author
-
James Y. Chen, Nan Guo, Phung Gip, Michael Zhang, Siddhartha Mitra, Mckenna Kelly Marie, Samuel H. Cheshier, Jens-Peter Volkmer, Mingye Feng, Rachel Weissman-Tsukamoto, Po Yi Ho, and Irving L. Weissman
- Subjects
Toll-like receptor ,Multidisciplinary ,biology ,CD47 ,Phagocytosis ,Macrophages ,Toll-Like Receptors ,Protein-Tyrosine Kinases ,Biological Sciences ,Cell biology ,Neoplasms ,Cancer cell ,biology.protein ,Agammaglobulinaemia Tyrosine Kinase ,Bruton's tyrosine kinase ,Macrophage ,Humans ,Signal transduction ,Calreticulin - Abstract
Significance Macrophage-mediated programmed cell removal (PrCR) plays an essential role in tumor surveillance and elimination. Blockade of the don't-eat-me signal CD47 on tumor cells allows already expressed eat-me signals to induce PrCR to eliminate tumor cells. To date the molecular mechanism by which macrophages recognize and phagocytose tumor cells remains unclear. This paper demonstrates that the activation of Toll-like receptor (TLR) pathways in macrophages induces the phosphorylation of Bruton's tyrosine kinase (Btk), which catalyzes cell-surface exposure of calreticulin. Calreticulin on or secreted by macrophages plays a critical role in mediating adjacent tumor cell recognition and phagocytosis. These findings reveal a strategy to enhance the efficacy of PrCR through a combination of TLR/Btk activation and CD47 blockade, and advance our understanding of the underlying mechanism of macrophage-mediated PrCR of tumor cells.
- Published
- 2015